MIGUEL RODRIGUEZ: Open Payments
NPI 1568854966 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,826 in 90 payments from 19 companies in 2025. Trend: 2023 $5,831 · 2024 $2,160 · 2025 $1,826
Food & beverage: $1,826
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $576 |
| UCB, Inc. | 10 | $238 |
| Novartis Pharmaceuticals Corporation | 11 | $191 |
| AstraZeneca Pharmaceuticals LP | 5 | $136 |
| Mallinckrodt Hospital Products Inc. | 8 | $135 |
| ANI Pharmaceuticals, Inc. | 5 | $111 |
| GENZYME CORPORATION | 4 | $87 |
| Amgen Inc. | 3 | $73 |
| PFIZER INC. | 3 | $50 |
| Janssen Biotech, Inc. | 2 | $40 |
Products named: RINVOQ, Bimzelx, COSENTYX, SKYRIZI, SAPHNELO, ACTHAR, PURIFIED CORTROPHIN GEL, KEVZARA.
Industry payments across TX — which companies pay providers there.
